Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Prostatic Neoplasms 6Polycystic Ovary Syndrome 3Infertility 2Ovarian Hyperstimulation Syndrome 1Neoplasms 1Metabolic Syndrome 1Hypogonadism 1Fatty Liver 1

Interventions

Clomiphene 13Metformin 7Menotropins 4Letrozole 4Chorionic Gonadotropin 3ulipristal acetate 2cetrorelix 2Triptorelin Pamoate 2Sperm Injections, Intracytoplasmic 2Liraglutide 2follitropin beta 1follitropin alfa 1Solutions 1Progestins 1Progesterone 1Prednisolone 1Oils 1Methylprednisolone 1Medroxyprogesterone Acetate 1Leuprolide 1Inositol 1Injections 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Danazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Infertility × Triptorelin Pamoate × Clear all
NCT04727671 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Damascus University

Phase 4 Completed
50 enrolled

Infertility, Polycystic Ovary Syndrome

NCT04727684 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Damascus University

Phase 4 Completed
50 enrolled

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡